A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial of olanzapine plus triple antiemetic regimen for the prevention of multiday highly emetogenic chemotherapy-induced nausea and vomiting (OFFER study)
一项多中心、随机、双盲、安慰剂对照的 3 期试验，研究奥氮平联合三联止吐方案预防多日高致吐性化疗引起的恶心和呕吐（OFFER 研究）
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2022.101771
Zhao, Yuanyuan; Yang, Yunpeng; Gao, Fangfang; Hu, Changlu; Zhong, Diansheng; Lu, Miaozhen; Yuan, Zhiping; Zhao, Jianqing; Miao, Jidong; Li, Yan; Zhu, Jie; Wang, Chunbin; Han, Jianjun; Zhao, Yanqiu; Huang, Yan; Zhang, Li
